This bill, called the PI Post Acute Access Act, would change a part of Medicare law (title XVIII of the Social Security Act). It adds intravenous immune globulin (IVIG) used to treat primary immunodeficiency and related items and services to a specific Medicare payment provision for skilled nursing facilities. The addition lists current HCPCS codes (J1561, J1569, J1576, J1568, J1459, J1554, J1557, J1566) and allows the Secretary to update codes. The change would apply to items and services furnished on or after October 1, 2026.
If you are a Medicare beneficiary with a primary immunodeficiency who receives care in a skilled nursing facility, this bill would add IVIG and related services to a Medicare provision that addresses skilled nursing facility payments. The bill’s stated purpose is to improve access to those services in post-acute skilled nursing settings.
No publicly available information.
The bill’s title and text state the goal is to improve access to skilled nursing facility services for patients with primary immunodeficiency by explicitly adding IVIG and related items to the named Medicare payment provision. The amendment names specific HCPCS codes and takes effect October 1, 2026.
No publicly available information.